KRISTI ORBAUGH: Open Payments
NPI 1134191679 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250,975 in 419 payments from 13 companies in 2025. Trend: 2023 $290,584 · 2024 $250,419 · 2025 $250,975
Speaker / faculty: $150,223Travel & lodging: $74,866Consulting: $14,926Food & beverage: $6,538Speaker / faculty: $4,423
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 125 | $74,279 |
| Daiichi Sankyo Inc. | 110 | $71,961 |
| Stemline Therapeutics Inc. | 42 | $22,760 |
| Lilly USA, LLC | 39 | $21,042 |
| Gilead Sciences, Inc. | 38 | $17,265 |
| PFIZER INC. | 16 | $15,708 |
| SOBI, INC | 15 | $9,584 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 15 | $8,810 |
| Exelixis Inc. | 8 | $6,030 |
| E.R. Squibb & Sons, L.L.C. | 7 | $2,115 |
Products named: Enhertu, DATROWAY, Orserdu, Trodelvy, IBRANCE, VERZENIO, Vonjo, IMFINZI.
Industry payments across IN — which companies pay providers there.
